Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06913959

HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)

The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

HIV-1 is divided four distinct groups: M (major) which represents the pandemic strains while others groups O (outlier), N (non M, non O) and P are called non-M variants. Group O (HIV-O) is more divergent, endemic in Central Africa and Cameroon, where it represents about 1% of HIV infections. These variants are characterized by an important genetic divergence from pandemic HIV-1 group M (HIV-M), which impacts on the diagnosis, monitoring and treatment of infected patients. Although discovered in 1990, and emerged at the same time as HIV-M, no data of epidemiology, natural history and evolution of the genetic diversity of these variants is currently available. The few knowledge available to date come from sporadic cases, mainly through studies in Yaoundé. It is therefore essential to improve current knowledge on these variants and their consequences on infected patients.

The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All available samples tested positive for HIV during the national Health survey of Cameroon in 2011 And 2018
  • All Individuals who came to Centre Pasteur in Yaoundé or Garoua for HIV screening or viral load monitoring.

Exclusion criteria

  • Insufficient quantity or degraded Dried Blood Spot samples
  • All HIV-positive individuals aged less than 21 years, infected with a Group M HIV-1 virus, or those who refused to participate in the study

Treatment and study plan

Prospective

Diagnostic Test

Blood samples will be collected in order to meet the objectives of this substudy and possibly for complementary research

Primary outcomes

  1. Prevalence of non-M HIV-1 in Cameroon

    Time frame: 1 day

    Number of participants infected with non-M HIV-1 included compared to the total expected number of inclusions

Secondary outcomes

  1. Investigate the current molecular epidemiology of resistance in non-M HIV-1 variants in Cameroon

    Time frame: 1 Day

    Proportion of non-M HIV-1 samples characterized genotypically among the samples collected from participants included in the project

Other outcomes

  1. Study the current molecular epidemiology of HIV 1 non-M variant resistance in Cameroon

    Time frame: 1 day

    Proportion of non-M HIV-1 samples characterized for resistance among the samples collected from participants included in the project

Study contacts

Contact information is provided by the study sponsor or research team.

Elodie Alessandri-Gradt, ParmD PhD

CONTACT

[email protected]

+33232855885

Mariam Gharib, PhD

CONTACT

[email protected]

0144236442

Sponsors and collaborators

Lead sponsor

ANRS, Emerging Infectious Diseases

Other Gov

Collaborators

  • Centre Pasteur du Cameroun
  • University Hospital, Rouen

Registry information

Acronym: OBSOCAM

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Apr 6, 2025
Registry last updated
Apr 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.